PPTA Twitter

PlasmaProteins Individuals may donate #plasma through a process called plasmapheresis. This sterile, self-contained, and automated process separates plasma from other cellular components, which are then returned to the donor. Learn more: bit.ly/2SyNxTt pic.twitter.com/ZkdEYbDl0H
About 10 hours ago.
PlasmaProteins Thank you, @GovEvers for your commitment to International Plasma Awareness Week! #IPAW2019 pic.twitter.com/JK0Hs9YEBI
6 days ago.

New Supplement Addresses Hemolytic Complications of IVIG Infusions

A special supplement to the July issue of Transfusion, consisting of 19 referred papers, focuses on the frequency and pathogenesis of and strategies to mitigate intravenous immunoglobulin-mediated hemolysis.

Transfusion cover

In January 2014, PPTA, along with the Food and Drug Administration and the National Heart, Lung and Blood Institute, jointly hosted a workshop entitled, “Strategies to Address Hemolytic Complications of Immune Globulin Infusions.” The workshop examined strategies to reduce the occurrence and severity of hemolysis, including: patient risk factors, the potential of in vitro testing, and the link between hemolytic events and new indications for IG products. All of the strategies covered in the workshop are spotlighted in the new supplement.

George Schreiber, Sc.D., Director, PPTA Epidemiology, and Harvey Klein, M.D., Chief, Department of Transfusion Medicine, Clinical Center, NIH, served as guest editors of the supplement.

Transfusion is free to AABB members. Nonmembers may subscribe through Wiley-Blackwell or by calling +1.800.835.6770.


Copyright © 2018 PPTA. All rights reserved. (202) 789-3100